Showing results (571-580 of 583) with videos related to

Sort By:
Pageof 59
Science Translational Medicine|April 22, 2016
Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgiaLishuang Cao, Aoibhinn McDonnell, Anja Nitzsche, et al.
Preventive Veterinary Medicine|January 27, 2023
Factors associated with foot-and-mouth disease seroprevalence in small ruminants and identification of hot-spot areas in northern NigeriaMattia Begovoeva, David O Ehizibolo, Adeyinka J Adedeji, et al.
Bioorganic & Medicinal Chemistry|December 13, 2018
The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of painAlan D Brown, Sharan K Bagal, Paul Blackwell, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Discovery and Optimization of Selective Nav1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of PainSharan K Bagal, Peter J Bungay, Stephen M Denton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 15, 2024
The dementia care study (D-CARE): Recruitment strategies and demographic characteristics of participants in a pragmatic randomized trial of dementia careMia Yang, Rafael Samper-Ternent, Elena Volpi, et al.
Plos One|August 18, 2023
Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research ProgramHsueh-Han Yeh, Cathryn Peltz-Rauchman, Christine C Johnson, et al.
Nature Biotechnology|August 12, 2003
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitisWilliam H Robinson, Paulo Fontoura, Byung J Lee, et al.
British Journal of Pharmacology|January 28, 2015
A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitabilityClaire Elizabeth Payne, Adam R Brown, Jonathon W Theile, et al.
Pageof 59